Avant Garde/Avenir award for Investigators conducting high risk/high reward research on HIV and Substance Use (or Substance Use Disorders)
ID: FOR-DA-27-003 • Type: Forecasted
Question & Answer Assistant
Loading
Overview
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 5/28/25 the National Institutes of Health forecasted grant opportunity FOR-DA-27-003 for Avant Garde/Avenir award for Investigators conducting high risk/high reward research on HIV and Substance Use (or Substance Use Disorders).
The grant will be issued under grant program 93.279 Drug Abuse and Addiction Research Programs.
Timing
Forecast Posted Date
May 28, 2025, 12:00 a.m. EDT
Est. Application Posting Date
March 9, 2026, 12:00 a.m. EDT
Est. Synopsis Response Date
Aug. 15, 2026, 12:00 a.m. EDT Forecasted
Last Updated
July 17, 2025, 12:08 p.m. EDT
Version
2
Eligibility
Eligible Applicants
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
County governments
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
State governments
For profit organizations other than small businesses
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
County governments
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
State governments
For profit organizations other than small businesses
Independent school districts
Contacts
Contact
Vasundhara Varthakavi, DVM, Ph.D.
National Institute on Drug Abuse (NIDA)
Contact Email